Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ecopia
U.S. Patent and Trademark office confirms composition-of-matter claims on Ecopia's ECO-4601
August 18th, 2006
Ecopia is pleased to announce that The United States Patent and Trademark Office (USPTO) has confirmed allowance of U.S. patent application USSN 10/762,107, including notably the composition-of-matter claims directed to Ecopia's lead drug candidate ECO-4601. In 2005, the USPTO had issued a first Notice of Allowance for the application and had then withdrawn it in April 2006, due to a mistake on the part of the office, returning the application to examination for further review. By way of a second Notice of Allowance issued July 12, 2006, the USPTO has now re-affirmed its initial decision that the claimed structure of drug candidate ECO-4601 and methods for its...
Source: Biotech Law Weekly (2006-08-18)
|
